Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-03-01 @ 3:01 PM
Study NCT ID:
NCT03840902
Status:
TERMINATED
Last Update Posted:
2024-01-16
First Post:
2019-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-small Cell Lung Cancer | View |